U.S. markets open in 1 hour 57 minutes
  • S&P Futures

    3,713.50
    +43.50 (+1.19%)
     
  • Dow Futures

    29,610.00
    +267.00 (+0.91%)
     
  • Nasdaq Futures

    11,474.25
    +158.00 (+1.40%)
     
  • Russell 2000 Futures

    1,685.10
    +22.60 (+1.36%)
     
  • Crude Oil

    77.54
    +0.83 (+1.08%)
     
  • Gold

    1,646.50
    +13.10 (+0.80%)
     
  • Silver

    18.69
    +0.22 (+1.16%)
     
  • EUR/USD

    0.9637
    +0.0025 (+0.26%)
     
  • 10-Yr Bond

    3.8780
    0.0000 (0.00%)
     
  • Vix

    31.17
    +1.25 (+4.18%)
     
  • GBP/USD

    1.0815
    +0.0131 (+1.23%)
     
  • USD/JPY

    144.3730
    -0.3070 (-0.21%)
     
  • BTC-USD

    20,217.32
    +1,299.06 (+6.87%)
     
  • CMC Crypto 200

    461.63
    +28.53 (+6.59%)
     
  • FTSE 100

    7,013.90
    -7.05 (-0.10%)
     
  • Nikkei 225

    26,571.87
    +140.32 (+0.53%)
     

Should You Already Consider Disposing Your Humana (HUM) Shares?

·2 min read

Oakmark Funds, an investment management firm, published its “Oakmark Global Select Fund” second quarter 2022 investor letter – a copy that can be downloaded here. The Oakmark Global Select Fund returned -16.7% for the quarter ending June 30, underperforming the MSCI World Index (NET), which returned -16.2%. Year-to-date, the Fund returned -22.6% compared to the benchmark's return of -20.5%. Since its September 2006 inception, the Fund has earned an annualized return of 6.9% per year. Go over the fund’s top 5 positions to have a glimpse of its finest picks for 2022.

In its Q2 2022 investor letter, Oakmark Global Select Fund mentioned Humana Inc. (NYSE:HUM) and explained its insights for the company. Founded in 1961, Humana Inc. (NYSE:HUM) is a Louisville, Kentucky-based health insurance company with a $61.1 billion market capitalization. Humana Inc. (NYSE:HUM) delivered a 4.27% return since the beginning of the year, while its 12-month returns are up by 4.36%. The stock closed at $483.69 per share on July 20, 2022.

Here is what Oakmark Global Select Fund has to say about Humana Inc. (NYSE:HUM) in its Q2 2022 investor letter:

"During the quarter, we also sold our position in Humana (NYSE:HUM) in favor of names that, in our opinion, offer more potential upside. Geographically, we ended the quarter with 53% of the portfolio in the U.S., 38% in the U.K. and Europe, and 9% in Asia."

Copyright: andreypopov / 123RF Stock Photo

Our calculations show that Humana Inc. (NYSE:HUM) fell short and didn’t make it on our list of the 30 Most Popular Stocks Among Hedge Funds. Humana Inc. (NYSE:HUM) was in 66 hedge fund portfolios at the end of the second quarter of 2022, compared to 66 funds in the previous quarter. Humana Inc. (NYSE:HUM) delivered a 3.91% return in the past 3 months.

In April 2021, we also shared another hedge fund’s views on Humana Inc. (NYSE:HUM) in another article. You can find other investor letters from hedge funds and prominent investors on our hedge fund investor letters 2022 Q2 page.

Disclosure: None. This article is originally published at Insider Monkey.